EP0277250A1 - Process for inducing secondary metabolite production in plant cultures and means thereof - Google Patents
Process for inducing secondary metabolite production in plant cultures and means thereofInfo
- Publication number
- EP0277250A1 EP0277250A1 EP87904973A EP87904973A EP0277250A1 EP 0277250 A1 EP0277250 A1 EP 0277250A1 EP 87904973 A EP87904973 A EP 87904973A EP 87904973 A EP87904973 A EP 87904973A EP 0277250 A1 EP0277250 A1 EP 0277250A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- process according
- cells
- plant
- alkaloids
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000000034 method Methods 0.000 title claims description 51
- 229930000044 secondary metabolite Natural products 0.000 title claims description 35
- 230000008569 process Effects 0.000 title claims description 30
- 230000001939 inductive effect Effects 0.000 title claims description 25
- 238000004519 manufacturing process Methods 0.000 title description 19
- 150000001875 compounds Chemical class 0.000 claims abstract description 42
- 229930013930 alkaloid Natural products 0.000 claims abstract description 36
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 26
- 240000001829 Catharanthus roseus Species 0.000 claims abstract description 21
- 239000002253 acid Substances 0.000 claims abstract description 17
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims abstract description 13
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 13
- 239000011780 sodium chloride Substances 0.000 claims abstract description 13
- 239000000725 suspension Substances 0.000 claims abstract description 13
- 238000003786 synthesis reaction Methods 0.000 claims abstract description 12
- 229910021578 Iron(III) chloride Inorganic materials 0.000 claims abstract description 6
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 claims abstract description 6
- 150000005846 sugar alcohols Chemical class 0.000 claims abstract description 4
- 239000003448 gibberellin Substances 0.000 claims abstract description 3
- 241000196324 Embryophyta Species 0.000 claims description 56
- GKWYINOZGDHWRA-UHFFFAOYSA-N catharanthine Natural products C1C(CC)(O)CC(CC2C(=O)OC)CN1CCC1=C2NC2=CC=CC=C12 GKWYINOZGDHWRA-UHFFFAOYSA-N 0.000 claims description 12
- CMKFQVZJOWHHDV-DYHNYNMBSA-N catharanthine Chemical compound C([C@@H]1C=C([C@@H]2[C@@]3(C1)C(=O)OC)CC)N2CCC1=C3NC2=CC=CC=C12 CMKFQVZJOWHHDV-DYHNYNMBSA-N 0.000 claims description 10
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 9
- CZJDUZOWQVAEEV-XIEZEKGWSA-N (+)-19-epi-Ajmalicine Natural products O=C(OC)C=1[C@@H]2[C@@H]([C@@H](C)OC=1)C[N+]1[C@H](c3[nH]c4c(c3CC1)cccc4)C2 CZJDUZOWQVAEEV-XIEZEKGWSA-N 0.000 claims description 8
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 8
- GRTOGORTSDXSFK-XJTZBENFSA-N ajmalicine Chemical compound C1=CC=C2C(CCN3C[C@@H]4[C@H](C)OC=C([C@H]4C[C@H]33)C(=O)OC)=C3NC2=C1 GRTOGORTSDXSFK-XJTZBENFSA-N 0.000 claims description 8
- 229940007897 ajmalicine Drugs 0.000 claims description 8
- -1 halide salt Chemical class 0.000 claims description 8
- ZLQMRLSBXKQKMG-UHFFFAOYSA-N rauniticine Natural products COC(=O)C1=CC2CC3N(CCc4c3[nH]c5ccccc45)CC2C(C)O1 ZLQMRLSBXKQKMG-UHFFFAOYSA-N 0.000 claims description 8
- 239000000600 sorbitol Substances 0.000 claims description 8
- 235000010356 sorbitol Nutrition 0.000 claims description 8
- 230000008723 osmotic stress Effects 0.000 claims description 7
- 239000005648 plant growth regulator Substances 0.000 claims description 6
- 238000004114 suspension culture Methods 0.000 claims description 5
- 229930005303 indole alkaloid Natural products 0.000 claims description 3
- 150000002475 indoles Chemical class 0.000 claims description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 2
- 229930195725 Mannitol Natural products 0.000 claims description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 2
- 239000000594 mannitol Substances 0.000 claims description 2
- 235000010355 mannitol Nutrition 0.000 claims description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 2
- 239000000811 xylitol Substances 0.000 claims description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 2
- 235000010447 xylitol Nutrition 0.000 claims description 2
- 229960002675 xylitol Drugs 0.000 claims description 2
- 150000002894 organic compounds Chemical class 0.000 claims 1
- 210000004027 cell Anatomy 0.000 abstract description 53
- 239000000411 inducer Substances 0.000 abstract description 16
- 230000003204 osmotic effect Effects 0.000 abstract description 8
- 150000007513 acids Chemical class 0.000 abstract description 6
- 239000003795 chemical substances by application Substances 0.000 abstract description 3
- 210000004748 cultured cell Anatomy 0.000 abstract description 3
- 230000008635 plant growth Effects 0.000 abstract description 3
- 150000003839 salts Chemical class 0.000 abstract description 2
- 239000000126 substance Substances 0.000 description 25
- 239000002207 metabolite Substances 0.000 description 15
- 230000006698 induction Effects 0.000 description 13
- 239000002609 medium Substances 0.000 description 13
- 150000003797 alkaloid derivatives Chemical class 0.000 description 11
- 230000000694 effects Effects 0.000 description 9
- 230000012010 growth Effects 0.000 description 9
- 239000000243 solution Substances 0.000 description 8
- JLIDBLDQVAYHNE-YKALOCIXSA-N (+)-Abscisic acid Chemical compound OC(=O)/C=C(/C)\C=C\[C@@]1(O)C(C)=CC(=O)CC1(C)C JLIDBLDQVAYHNE-YKALOCIXSA-N 0.000 description 7
- 229960002920 sorbitol Drugs 0.000 description 7
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 235000015097 nutrients Nutrition 0.000 description 6
- 230000035882 stress Effects 0.000 description 6
- 230000004044 response Effects 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 239000002028 Biomass Substances 0.000 description 4
- FAIXYKHYOGVFKA-UHFFFAOYSA-N Kinetin Natural products N=1C=NC=2N=CNC=2C=1N(C)C1=CC=CO1 FAIXYKHYOGVFKA-UHFFFAOYSA-N 0.000 description 4
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 238000004113 cell culture Methods 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- QANMHLXAZMSUEX-UHFFFAOYSA-N kinetin Chemical compound N=1C=NC=2N=CNC=2C=1NCC1=CC=CO1 QANMHLXAZMSUEX-UHFFFAOYSA-N 0.000 description 4
- 229960001669 kinetin Drugs 0.000 description 4
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- 241000157855 Cinchona Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 240000001090 Papaver somniferum Species 0.000 description 3
- JXLYSJRDGCGARV-WWYNWVTFSA-N Vinblastine Natural products O=C(O[C@H]1[C@](O)(C(=O)OC)[C@@H]2N(C)c3c(cc(c(OC)c3)[C@]3(C(=O)OC)c4[nH]c5c(c4CCN4C[C@](O)(CC)C[C@H](C3)C4)cccc5)[C@@]32[C@H]2[C@@]1(CC)C=CCN2CC3)C JXLYSJRDGCGARV-WWYNWVTFSA-N 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 230000003698 anagen phase Effects 0.000 description 3
- 239000006285 cell suspension Substances 0.000 description 3
- 229960004126 codeine Drugs 0.000 description 3
- FCRACOPGPMPSHN-UHFFFAOYSA-N desoxyabscisic acid Natural products OC(=O)C=C(C)C=CC1C(C)=CC(=O)CC1(C)C FCRACOPGPMPSHN-UHFFFAOYSA-N 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000006870 ms-medium Substances 0.000 description 3
- 238000004161 plant tissue culture Methods 0.000 description 3
- 229960003048 vinblastine Drugs 0.000 description 3
- JXLYSJRDGCGARV-XQKSVPLYSA-N vincaleukoblastine Chemical compound C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 JXLYSJRDGCGARV-XQKSVPLYSA-N 0.000 description 3
- OGWKCGZFUXNPDA-XQKSVPLYSA-N vincristine Chemical compound C([N@]1C[C@@H](C[C@]2(C(=O)OC)C=3C(=CC4=C([C@]56[C@H]([C@@]([C@H](OC(C)=O)[C@]7(CC)C=CCN([C@H]67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)C[C@@](C1)(O)CC)CC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-XQKSVPLYSA-N 0.000 description 3
- 229960004528 vincristine Drugs 0.000 description 3
- OGWKCGZFUXNPDA-UHFFFAOYSA-N vincristine Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(OC(C)=O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-UHFFFAOYSA-N 0.000 description 3
- JSLDLCGKZDUQSH-RTBUJCADSA-N 19-epivindolinine Natural products O=C(OC)[C@H]1[C@@]23[C@H](C)[C@]4([C@@H]5N(CC=C4)CC[C@]25c2c(N3)cccc2)C1 JSLDLCGKZDUQSH-RTBUJCADSA-N 0.000 description 2
- 244000068687 Amelanchier alnifolia Species 0.000 description 2
- 235000009027 Amelanchier alnifolia Nutrition 0.000 description 2
- 235000001258 Cinchona calisaya Nutrition 0.000 description 2
- 240000001879 Digitalis lutea Species 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- GFSQDOUEUWXRSL-UHFFFAOYSA-N Lunularic acid Chemical compound OC(=O)C1=C(O)C=CC=C1CCC1=CC=C(O)C=C1 GFSQDOUEUWXRSL-UHFFFAOYSA-N 0.000 description 2
- 235000008753 Papaver somniferum Nutrition 0.000 description 2
- KILNDJCLJBOWAN-UHFFFAOYSA-N Tabersonine Natural products CCC12CC(=C3N(C)c4cc(OC)ccc4C35CCN(CC=C1)C25)C(=O)OC KILNDJCLJBOWAN-UHFFFAOYSA-N 0.000 description 2
- WVTGEXAIVZDLCR-UHFFFAOYSA-N Vindoline Natural products CC1C2CN3CCCC14CCC5Nc6ccccc6C25C34 WVTGEXAIVZDLCR-UHFFFAOYSA-N 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000005712 elicitor Substances 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229960005181 morphine Drugs 0.000 description 2
- 229930010796 primary metabolite Natural products 0.000 description 2
- 229960000948 quinine Drugs 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- FNGGIPWAZSFKCN-ACRUOGEOSA-N tabersonine Chemical compound N1C2=CC=CC=C2[C@]2([C@H]34)C1=C(C(=O)OC)C[C@]3(CC)C=CCN4CC2 FNGGIPWAZSFKCN-ACRUOGEOSA-N 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- IHIXIJGXTJIKRB-UHFFFAOYSA-N trisodium vanadate Chemical compound [Na+].[Na+].[Na+].[O-][V]([O-])([O-])=O IHIXIJGXTJIKRB-UHFFFAOYSA-N 0.000 description 2
- APJYDQYYACXCRM-UHFFFAOYSA-N tryptamine Chemical compound C1=CC=C2C(CCN)=CNC2=C1 APJYDQYYACXCRM-UHFFFAOYSA-N 0.000 description 2
- CXBGOBGJHGGWIE-IYJDUVQVSA-N vindoline Chemical compound CN([C@H]1[C@](O)([C@@H]2OC(C)=O)C(=O)OC)C3=CC(OC)=CC=C3[C@]11CCN3CC=C[C@]2(CC)[C@@H]13 CXBGOBGJHGGWIE-IYJDUVQVSA-N 0.000 description 2
- FNGGIPWAZSFKCN-UHFFFAOYSA-N xi-tabersonine Natural products N1C2=CC=CC=C2C2(C34)C1=C(C(=O)OC)CC3(CC)C=CCN4CC2 FNGGIPWAZSFKCN-UHFFFAOYSA-N 0.000 description 2
- CSKKDSFETGLMSB-NRZPKYKESA-N (-)-secologanin Chemical compound C=C[C@@H]1[C@H](CC=O)C(C(=O)OC)=CO[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CSKKDSFETGLMSB-NRZPKYKESA-N 0.000 description 1
- VCWMRQDBPZKXKG-UHFFFAOYSA-N (2S)-O1-alpha-D-Galactopyranosyl-myo-inosit Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(O)C1O VCWMRQDBPZKXKG-UHFFFAOYSA-N 0.000 description 1
- 239000001707 (E,7R,11R)-3,7,11,15-tetramethylhexadec-2-en-1-ol Substances 0.000 description 1
- KJTLQQUUPVSXIM-ZCFIWIBFSA-N (R)-mevalonic acid Chemical compound OCC[C@](O)(C)CC(O)=O KJTLQQUUPVSXIM-ZCFIWIBFSA-N 0.000 description 1
- PRPINYUDVPFIRX-UHFFFAOYSA-N 1-naphthaleneacetic acid Chemical group C1=CC=C2C(CC(=O)O)=CC=CC2=C1 PRPINYUDVPFIRX-UHFFFAOYSA-N 0.000 description 1
- LNETULKMXZVUST-UHFFFAOYSA-N 1-naphthoic acid Chemical compound C1=CC=C2C(C(=O)O)=CC=CC2=C1 LNETULKMXZVUST-UHFFFAOYSA-N 0.000 description 1
- HDHKIYSRJLSYJR-UHFFFAOYSA-N 2-[2,6-dichloro-3-[2,4-dichloro-3-[2-(diethylamino)ethyl]phenoxy]phenyl]-n,n-diethylethanamine Chemical compound CCN(CC)CCC1=C(Cl)C=CC(OC=2C(=C(CCN(CC)CC)C(Cl)=CC=2)Cl)=C1Cl HDHKIYSRJLSYJR-UHFFFAOYSA-N 0.000 description 1
- OJJHKXKXZMBCHJ-UHFFFAOYSA-N 20-Hydroxyrutacridone epoxide Chemical compound C1C2=C3N(C)C4=CC=CC=C4C(=O)C3=C(O)C=C2OC1C1(CO)CO1 OJJHKXKXZMBCHJ-UHFFFAOYSA-N 0.000 description 1
- XBAMJZTXGWPTRM-NTXHKPOFSA-N 3alpha(S)-strictosidine Chemical compound O([C@@H]1OC=C([C@H]([C@H]1C=C)C[C@H]1C2=C(C3=CC=CC=C3N2)CCN1)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O XBAMJZTXGWPTRM-NTXHKPOFSA-N 0.000 description 1
- HNRGNQMAJHAVCN-UHFFFAOYSA-N 4'-dihydrophaseic acid Natural products CC(=CC(=O)O)C=CC1(C)C2(C)COC1(O)CC(O)C2 HNRGNQMAJHAVCN-UHFFFAOYSA-N 0.000 description 1
- JLIDBLDQVAYHNE-UHFFFAOYSA-N 5-(1-hydroxy-2,6,6-trimethyl-4-oxo-1-cyclohex-2-enyl)-3-methylpenta-2,4-dienoic acid Chemical group OC(=O)C=C(C)C=CC1(O)C(C)=CC(=O)CC1(C)C JLIDBLDQVAYHNE-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- IVHVNMLJNASKHW-UHFFFAOYSA-M Chlorphonium chloride Chemical compound [Cl-].CCCC[P+](CCCC)(CCCC)CC1=CC=C(Cl)C=C1Cl IVHVNMLJNASKHW-UHFFFAOYSA-M 0.000 description 1
- 235000021513 Cinchona Nutrition 0.000 description 1
- 244000182633 Cinchona succirubra Species 0.000 description 1
- 235000006768 Cinchona succirubra Nutrition 0.000 description 1
- 241000501458 Cultus Species 0.000 description 1
- KJTLQQUUPVSXIM-UHFFFAOYSA-N DL-mevalonic acid Natural products OCCC(O)(C)CC(O)=O KJTLQQUUPVSXIM-UHFFFAOYSA-N 0.000 description 1
- NOQGZXFMHARMLW-UHFFFAOYSA-N Daminozide Chemical compound CN(C)NC(=O)CCC(O)=O NOQGZXFMHARMLW-UHFFFAOYSA-N 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- VCWMRQDBPZKXKG-FOHCLANXSA-N Galactinol Natural products O([C@@H]1[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O1)C1[C@@H](O)[C@@H](O)C(O)[C@@H](O)[C@H]1O VCWMRQDBPZKXKG-FOHCLANXSA-N 0.000 description 1
- 241001608331 Gonyaulax digitale Species 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- JRMIBKXNMDYCPR-UHFFFAOYSA-N Hydroxyrutacridone epoxide Natural products OC1C2=C3N(C)C4=CC=CC=C4C(=O)C3=C(O)C=C2OC1C1(C)CO1 JRMIBKXNMDYCPR-UHFFFAOYSA-N 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 229910020700 Na3VO4 Inorganic materials 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 240000009164 Petroselinum crispum Species 0.000 description 1
- YNCRBFODOPHHAO-YUELXQCFSA-N Phaseic acid Natural products CC(=CC(=O)O)C=C[C@@H]1[C@@]2(C)CO[C@@]1(C)CC(=O)C2 YNCRBFODOPHHAO-YUELXQCFSA-N 0.000 description 1
- 235000006089 Phaseolus angularis Nutrition 0.000 description 1
- BLUHKGOSFDHHGX-UHFFFAOYSA-N Phytol Natural products CC(C)CCCC(C)CCCC(C)CCCC(C)C=CO BLUHKGOSFDHHGX-UHFFFAOYSA-N 0.000 description 1
- 235000008124 Picea excelsa Nutrition 0.000 description 1
- 240000000020 Picea glauca Species 0.000 description 1
- 235000008127 Picea glauca Nutrition 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000223254 Rhodotorula mucilaginosa Species 0.000 description 1
- 240000005746 Ruta graveolens Species 0.000 description 1
- 235000001347 Ruta graveolens Nutrition 0.000 description 1
- YXQGLAPCZDYVLL-UHFFFAOYSA-N Rutacridone epoxide Chemical compound C1C2=C3N(C)C4=CC=CC=C4C(=O)C3=C(O)C=C2OC1C1(C)CO1 YXQGLAPCZDYVLL-UHFFFAOYSA-N 0.000 description 1
- YXQGLAPCZDYVLL-HNAYVOBHSA-N Rutacridone epoxide Natural products O=C1c2c(O)cc3O[C@H]([C@]4(C)OC4)Cc3c2N(C)c2c1cccc2 YXQGLAPCZDYVLL-HNAYVOBHSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- CSKKDSFETGLMSB-FUJZYWHJSA-N Secologanin Natural products C=C[C@@H]1[C@H](CC=O)C(C(=O)OC)=CO[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CSKKDSFETGLMSB-FUJZYWHJSA-N 0.000 description 1
- OXAGNIAQEYWXSM-JJEHOMFVSA-N Strictosidine Natural products CC(=O)OC1=CO[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](C=C)[C@@H]1C[C@@H]3NCCc4c3[nH]c5ccccc45 OXAGNIAQEYWXSM-JJEHOMFVSA-N 0.000 description 1
- HNZBNQYXWOLKBA-UHFFFAOYSA-N Tetrahydrofarnesol Natural products CC(C)CCCC(C)CCCC(C)=CCO HNZBNQYXWOLKBA-UHFFFAOYSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 240000007098 Vigna angularis Species 0.000 description 1
- 235000010711 Vigna angularis Nutrition 0.000 description 1
- BLGXFZZNTVWLAY-CCZXDCJGSA-N Yohimbine Natural products C1=CC=C2C(CCN3C[C@@H]4CC[C@@H](O)[C@H]([C@H]4C[C@H]33)C(=O)OC)=C3NC2=C1 BLGXFZZNTVWLAY-CCZXDCJGSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- BOTWFXYSPFMFNR-OALUTQOASA-N all-rac-phytol Natural products CC(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)=CCO BOTWFXYSPFMFNR-OALUTQOASA-N 0.000 description 1
- VCWMRQDBPZKXKG-DXNLKLAMSA-N alpha-D-galactosyl-(1->3)-1D-myo-inositol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@@H]1O VCWMRQDBPZKXKG-DXNLKLAMSA-N 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 239000001166 ammonium sulphate Substances 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- BLGXFZZNTVWLAY-UHFFFAOYSA-N beta-Yohimbin Natural products C1=CC=C2C(CCN3CC4CCC(O)C(C4CC33)C(=O)OC)=C3NC2=C1 BLGXFZZNTVWLAY-UHFFFAOYSA-N 0.000 description 1
- 150000003842 bromide salts Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 229940097217 cardiac glycoside Drugs 0.000 description 1
- 239000002368 cardiac glycoside Substances 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000036978 cell physiology Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 150000003841 chloride salts Chemical class 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- UHZZMRAGKVHANO-UHFFFAOYSA-M chlormequat chloride Chemical compound [Cl-].C[N+](C)(C)CCCl UHZZMRAGKVHANO-UHFFFAOYSA-M 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 125000000332 coumarinyl group Chemical class O1C(=O)C(=CC2=CC=CC=C12)* 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- UQHKFADEQIVWID-UHFFFAOYSA-N cytokinin Natural products C1=NC=2C(NCC=C(CO)C)=NC=NC=2N1C1CC(O)C(CO)O1 UQHKFADEQIVWID-UHFFFAOYSA-N 0.000 description 1
- 239000004062 cytokinin Substances 0.000 description 1
- 230000000881 depressing effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- XBAMJZTXGWPTRM-UHFFFAOYSA-N epi-strictosidinic acid methyl ester Natural products C=CC1C(CC2C3=C(C4=CC=CC=C4N3)CCN2)C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O XBAMJZTXGWPTRM-UHFFFAOYSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 210000004349 growth plate Anatomy 0.000 description 1
- 239000003630 growth substance Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- INAXVFBXDYWQFN-XHSDSOJGSA-N morphinan Chemical class C1C2=CC=CC=C2[C@]23CCCC[C@H]3[C@@H]1NCC2 INAXVFBXDYWQFN-XHSDSOJGSA-N 0.000 description 1
- 229930013053 morphinan alkaloid Natural products 0.000 description 1
- IZGYIFFQBZWOLJ-UHFFFAOYSA-N neophaseic acid Natural products C1C(=O)CC2(C)OCC1(C)C2(O)C=CC(C)=CC(O)=O IZGYIFFQBZWOLJ-UHFFFAOYSA-N 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 235000011197 perejil Nutrition 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- IZGYIFFQBZWOLJ-CKAACLRMSA-N phaseic acid Chemical compound C1C(=O)C[C@@]2(C)OC[C@]1(C)[C@@]2(O)C=CC(/C)=C\C(O)=O IZGYIFFQBZWOLJ-CKAACLRMSA-N 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 150000003905 phosphatidylinositols Chemical class 0.000 description 1
- BOTWFXYSPFMFNR-PYDDKJGSSA-N phytol Chemical compound CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC\C(C)=C\CO BOTWFXYSPFMFNR-PYDDKJGSSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000003375 plant hormone Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 229930002341 quinoline alkaloid Natural products 0.000 description 1
- 150000003248 quinolines Chemical class 0.000 description 1
- 230000003938 response to stress Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000001229 ruta graveolens Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 238000013341 scale-up Methods 0.000 description 1
- CDAISMWEOUEBRE-CDRYSYESSA-N scyllo-inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O CDAISMWEOUEBRE-CDRYSYESSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 229930002534 steroid glycoside Natural products 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 150000008143 steroidal glycosides Chemical class 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229940125725 tranquilizer Drugs 0.000 description 1
- 239000003204 tranquilizing agent Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- BLGXFZZNTVWLAY-SCYLSFHTSA-N yohimbine Chemical compound C1=CC=C2C(CCN3C[C@@H]4CC[C@H](O)[C@@H]([C@H]4C[C@H]33)C(=O)OC)=C3NC2=C1 BLGXFZZNTVWLAY-SCYLSFHTSA-N 0.000 description 1
- 229960000317 yohimbine Drugs 0.000 description 1
- AADVZSXPNRLYLV-UHFFFAOYSA-N yohimbine carboxylic acid Natural products C1=CC=C2C(CCN3CC4CCC(C(C4CC33)C(O)=O)O)=C3NC2=C1 AADVZSXPNRLYLV-UHFFFAOYSA-N 0.000 description 1
- 229910000166 zirconium phosphate Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/182—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- C12N5/0025—Culture media for plant cell or plant tissue culture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/04—Plant cells or tissues
Definitions
- This invention relates to plant-derived secondary metabolites and, more particularly, to a method and means for inducing plant cells to produce these metabolites.
- a number of chemicals produced by plants are classified as primary metabolites since they are essential to cell function. While primary metabolites are ubiquitous in the plant population and comprise the majority of plant-produced chemicals, other compounds are classified as secondary metabolites and, because of their various applications, are the focus of both scientific investigation and commercial exploitation.
- secondary metabolites are produced by some plants in response to stress induced, for example, by microorganism infection, UV irradiation, mechanical wounding as well as by treatment with organic and inorganic substances.
- the variety of secondary metabolites produced under such stressful conditions is diverse and includes the alkaloids, terpenoids, flavonoids, carotenoids, phenolic compounds and glucosides.
- pharmaceutically useful secondary metabolites are the alkaloids, steroid hormones, cardiac glycosides and antibiotics, of which the indolic alkaloids are of particularly great interest.
- the alkaloids include many compounds, at least some of which are known to have therapeutic value.
- the indolic alkaloid ajmalicine is known to function as an antihypertensive/tranquilizer.
- vincristine and vinblastine are accepted in the treatment of cancers.
- Catharanthine a precursor of both vinblastine and vincristine, is also produced as a secondary metabolite and is valuable as a starting material in preparing those compounds.
- metabolite produced depends largely on the plant species. For example, some indolic alkaloids are extracted most commonly from Catharanthus roseus (also known as Madagascar periwinkle, Vinea rosea and Lochnera rosea). Further, morphinan alkaloids e.g. morphine and codeine, are extracted from poppy plants (Papaver somniferum) and Cinchona alkaloids e.g. quinine and related quinoline alkaloids, are derived from Cinchona succirubra and related species. Obviously, the plant from which the secondary metabolite is to be derived must be genetically capable of expressing the metabolite and must be receptive to a particular metabolic stimulus in order to engage in synthesis of the metabolite.
- Plant tissue culture entails growth of a population of plant cells suspended within nutrient broth using a level agitation which strikes a balance between the need to circulate nutrients throughout the culture and the fragility of the plant cells. Not all plants are amenable to this procedure, however, and the media constitution is also a major factor in the success of the method.
- Advantages of the ptc technique reside in the ability to exercise control over the growth conditions in terms of defined environment, nutrient concentration, and the like. Further, the capacity to circulate a stimulant within the culture broth allows the stimulant to contact a greater number of the individual cells or cell clumps in the broth by comparison with application of the stimulant to a callus whereby only the outermost cells may be effected.
- Eilert et al. disclose an attempt to induce production of the antimicrobial alkaloids rutacridone epoxide and hydroxyrutacridone epoxide from a suspension culture of Ruta graveolens.
- a suspension of either living free or immobilized yeasts or of dead Rhodotorula rubra cells or a crude cell wall fraction thereof they were able to show an increase in production of the antimicrobial compounds of interest.
- neither chitosan nor alginate were able to induce the desired response despite their having been proven to be useful as elicitors in other systems.
- the stress caused by the varied osmotic pressure is believed to be responsible for the increased synthesis.
- Those compounds which may be added to the plant cell suspension to generate osmotic stress may be selected from a very broad range of compounds. In general, these compounds may be categorized as ionic stress inducing compounds and organic stress inducing compounds. In either case, the end result of their addition to a suspension is the creation of an osmotic gradient between the cell and the surrounding medium.
- the ionic, stress-inducing compounds are preferably those halide salts able to ionize in solution. More preferably these salts are Group I or Group II halide salts, the Group numbers referring to the Periodic Table. Especially suitable such compounds include the Group I and Group II chlorides although the bromide salts are also suitable. In a limited sense, the invention extends to such compounds as the chloride salts of sodium, potassium and iron (preferably ferric).
- the organic, stress-inducing compounds include the sugar alcohols and sugar acids which include galactinol, xylitol, glycerol, mannitol and inositol and its various derivatives including phosphatidyl inositol, phytie acid and its esters, scyllitol, phytol, aldonic acids, aldaric acids, uronic acids and, notably, sorbitol. Sorbitol in particular has induced significant yields of secondary metabolites and is therefore preferred. Also within the scope of the present invention are compounds which act to induce secondary metabolite production by means other than through osmotic stress.
- This aspect of the present invention comprises culturing plant cells in a suspension supplemented with any one or a combination of a variety of plant growth regulating compounds and compounds which are related either by chemical structure or be biochemical function. While abscissic acid (ABA) is particularly useful, other related compounds which may be used include the antigibberellin compounds such as 2'-isopropyl-4'-(tri- methylammonium chloride)-5'-methylphenyl piperidine carboxylate, ⁇ -chloroethyltrimethylammonium chloride and tributyl-2,4-dichlorobenzyl phosphonium chloride.
- ABA abscissic acid
- other related compounds which may be used include the antigibberellin compounds such as 2'-isopropyl-4'-(tri- methylammonium chloride)-5'-methylphenyl piperidine carboxylate, ⁇ -chloroethyltrimethylammonium chloride and tributyl
- ABA-related compounds useful herein include N- (dimethyl- amino) succinamic acid, 4 ' -dihydrophaseic acid, phaseic acid and lunularic acid.
- Another aspect of the invention comprises a process for inducing synthesis of a secondary metabolite by plant cells which comprises growing said cells in the presence of a plant growth regulating compound or related such compound.
- the plant cells are cultured in a suspension supplemented with the regulator.
- the desired secondary metabolite or metabolites may be recovered using chemical procedures currently established in the biochemical extraction art.
- metabolites may simply be separated from the cells per se by concentrating the cells using conventional techniques such as centrifugation and filtration. Thereafter, the broth containing the metabolite may either be processed further to concentrate the metabolite by such techniques as dialysis or acted upon directly using standard chemical extraction techniques. Where the desired metabolite is expressed by the plant cell but is not secreted from it, the plant cells are broken open using, for example, increased pressure, either atmospheric or osmotic, or crushed. The metabolite may then be extracted in a suitable solvent and concentrated somewhat using procedures outlined above prior to chemical extraction of the desired secondary metabolite.
- a second aspect of the present invention comprises a method of providing a plant-cell derived secondary metabolite which comprises recovering the compound produced by way of the induction process of the present invention.
- the indolic alkaloids obtainable from Catharanthus roseus including NYCoganin and tryptophan-derived strictosidine, ajmalicine, yohimbine, tabersonine, vindoline and catharanthine as well as tryptamine; tyrosine-derived morphine and codeine from Papaver somniferum; phenylalanine-derived chemicals such as coumarins from parsley cell cultures; and mevalonic acid-derived chemicals such as saponins e.g. digitalis from Digitalis purpurea or D. lanata.
- the present invention related in a preferred aspect to the C . roseus derived indole alkaloids catharanthine, ajmalicine, tabersonine and vindoline.
- the inducing substance abscissic acid used herein is a known compound having the structural formula appearing below:
- Abscisic acid is an abscission-accelerating plant hormone i.e. a hormone which promotes separation of plant parts such as leaves from stems during the autumn season. It is a commercially available commodity known also as dormin whose commercial nomenclature is 5-(1hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)-3- methyl-2,4-pentadienoic acid. Synthetic forms of the drug as well as various cis-trans isomeric forms are also available commercially and may be used herein.
- plant cell culturing techniques are known and are used preferably herein.
- Conventional procedures are therefore employed in which living plant material e.g. leaf material, stem material or meristems are surface sterilized to prevent contamination and smaller masses of individual cells or cell clumps are nursed on agar nutrient base in growth plates until they may be transferred to a suitable liquid nutrient.
- the suspension is agitated continuously in culture flasks and ultimately transferred to a bioreactor. Agitation is suitably accomplished by the "air-lift" technique in which the culture is mixed by the gentle action of rising air bubbles.
- a solution of the inducing substance is suitably pre-prepared if desired in order to enhance homogeneity of the substance within the growth-sustaining medium.
- all substances of the present invention may be mixed with water prior to addition.
- Abscisic acid may be mixed with water and a few drops of base such as KOH to encourage dissolution if necessary.
- the preferred embodiment of the invention provides a method by which indolic alkaloids are produced by Catharanthus roseus.
- the C. roseus line from which the cultured cells are derived must, obviously, be amenable to plant tissue culturing. Obtaining such a line is well within the skill of persons to whom this disclosure is addressed and it is believed that several such lines presently exist. This is not to detract from the need to provide a plant whose cells have the capacity to endure and function within the cell culture environment. Those characteristics which confer this capacity are not well defined in the art. The presence of cells which are plant tissue culturable is confirmed almost exclusively by the trial and error approach. Thus, while specific cell lines having designations assigned by the inventors is used to exemplify the present invention hereinafter, it is to be acknowledged that the scope of the invention is by no means limited to these particular plant lines.
- C. roseus lines herein are designated JWM*, JOH and LBE-1.
- Lines JWM* and JOH were developed at the Plant Biotechnology Institute, Saskatoon, Sasketchewan, Canada.
- Line LBE-1 was developed at Allelix Inc., Mississauga, Ontario, Canada. All lines were originally isolated from C. roseus anthers.
- the C. roseus cells may be cultured in any liquid medium containing all necessary metabolites, examples of which include SH medium, LS medium and MS medium, all of which are known in the art.
- LS medium Lismair and Skoog
- SH medium Shinek-Hildebrandt
- MS medium Murashige and Skoog
- a carbon source such as sucrose or lactose.
- the sole growth regulator added to the SH medium is ⁇ -naphthaleneacetic acid, in a concentration of 2 mg/1.
- the medium also suitably contains kinetin (6-furfurylaminopurine) which is a synthetic cytokinin which functions in cell division.
- the plant cells are grown either in the dark to reduce stress and channel nutrients from light-activated secondary metabolic pathways (e.g. pigment formation) or light preferably until the population reaches the linear or early stationary growth phase at which time they are presumed to be more receptive to the inducing effects of the selected inducing preparation.
- the C. roseus cell suspension is grown in the absence of inducer preferably for from 3 to 10 days, more preferably for from 4 to 6 days under the conditions tested.
- the cell population may be monitored in order to identify the onset of the linear or early stationary growth phase if alternative growth conditions are employed.
- the inducing substance is introduced in amounts sufficient to establish a desired concentration within the broth.
- the inducing substances preferred herein are NaCl, KCl and FeCl 3 as ionic, osmotic stress inducers; sorbitol as organic, osmotic stress inducer and abscissic acid (ABA) as plant growth regulator inducer.
- the final broth concentration of either NaCl or KCl is suitably about 0.1 M, as a minimum desirable level. Lower levels may serve the inducing purpose but are unlikely to provide enhanced yields within the shortened time periods available with higher concentrations.
- the acceptable upper concentration level of NaCl or KCl is dictated by the osmotic pressure which its presence generates within the cultured cells. The upper limit is therefore slightly below that concentration which causes plasmolysis. More preferably, NaCl and KCl may be added to achieve broth concentrations of 0.01 M to 1.0 M and, ideally, at around 0.5 M. Ferric chloride is suitably added to the suspension medium to achieve a final concentration of from 10 - 500 ppm, more preferably from 20 - 200 ppm and, ideally, around 50 ppm.
- Broth concentrations of sorbitol range from about 0.05 M to a maximum concentration just slightly below the concentration at which plasmolysis occurs, as discussed with respect to NaCl or KCl addition.
- Preferred broth concentrations range from 0.1 M to 0.5 M and ideally at around 0.2 M.
- the ideal concentration of abscissic acid ranges from 0.1 mg- 0.5 mg per 60 mis of suspension. Concentrations as low as 0.01 mg may be used although the induction response may be unfavourably low. Concentrations higher than 0.5 mg/60 mls also may be used although there appears to be little enhancement of the effect seen at 0.5 mg/60 mis.
- the C. roseus cells are cultured for a period of time to allow the inducer to interface with the cells and stimulate indolic alkaloid production.
- a period of 2 - 5 days is preferred although variations of this preferred period are acceptable particularly where conditions are not as specifically described herein. Growth of the culture is preferably continued either in the dark or in light.
- the cells are harvested and the alkaloids extracted using conventional techniques. The particular techniques will depend on the specific substance to be recovered, but all are standard in the art.
- Embodiments of the invention are disclosed hereinafter with reference to the following examples.
- 60 ml cell suspension cultures are maintained in a basic MS growth medium containing 3% (w/v) sucrose, 2 mg/l ⁇ -naphthalenic acid and 0.1 mg kinetin.
- the cultures are maintained in 250 ml Erlenmeyer flasks on an illuminated rotary shaker (c. 120 rpm) and subcultured weekly by a one to five dilution.
- Abscisic acid and D-sorbitol were obtained from Sigma Chemical Company and NaCl, KCl and FeCl 3 from Fisher Scientific Limited.
- each inducer was added to the cell suspension on day 5 of the growth cycle as a filter-sterilized solution and the cells harvested three days later. Standard solvent extraction techniques were used to extract indolic alkaloids from the cells. Catharanthine and ajmalicine yields were quantified by HPLC analysis. The presence of other alkaloids was determined qualitatively by visualizing with eerie ammonium sulphate following TLC separation.
- Example 1 - ABA Induction Synthesic 99% pure abscissic acid was introduced in a range of concentrations from 0.1 - 2.0 mg/60 ml culture. The results generated appear in Tables 1 - 4 below. Table 1 shows the effect which the type and concentration of ABA has on the induction process as applied to cell line JOH. While the 99% pure ( ⁇ )cistrans synthetic isomer exhibited superior results, all forms of ABA showed desirable inducing properties.
- Table 2 illustrates the effect of ABA concentration on induction response on line JWM*. It will be noted that a maximum response occurs at 0.5 mg/60 ml culture with only minor variation with increased concentration.
- Table 3 the relationship of cell age and exposure to ABA is shown. It will be noted that atleast 3 days of culture growth provided the best results, with ajmalicine concentrations dropping off thereafter. However, catharanthine yields continue to rise even at day 6 of culture growth. The Table 3 results are with cell line JOH and an induction period of 4 days.
- Table 4 below shows the response to 1 mg ABA induction of a variety of cell lines each of which is available at either Allelix Inc. or the Plant Biology
- the plant cells have been observed to respond positively to ABA exposure by increased alkaloid production even after only one day of growth, when they are presumably still in lag phase. However, as alkaloid accumulation is to some extent biomass related, it is more appropriate to induce the cells once some increase in biomass has occurred.
- Example 2 Induction by NaCl
- a range of sodium chloride concentrations (from 0.1 - 1.0 g/60 ml flask) were tested for their effects on alkaloid accumulation in line JOH Table 5 below. High concentrations of NaCl reduce biomass, hence lowering alkaloid yields, whereas the effect on biomass of lower concentrations is offset by the stimulation of catharanthine production.
- Example 5 Induction by Sorbitol
- the major advantage obtained by inducing cell culture in accordance with the present invention is that yields of alkaloids (specifically catharanthine) can reach levels in only 8 days that in non-induced cells would take much longer to achieve, resulting in a considerably saving in terms of both time and cost.
- alkaloids specifically catharanthine
- the MS medium is enhanced preferably with 4% (w/v) sucrose as opposed to the 3% solution used on small scale, together with 1 mg/l ct-naphthalene acetic acid and 0.1 mg/l kinetin. All lines and chemicals remain the same.
- Example 6 Larger Scale Induction Process
- solutions are preferably prepared to give 8.33 mg/1 in the final culture fluid.
- Solutions are prepared in 1 liter of distilled water, filter sterilized and injected into the fermenter from a sterile bottle.
- Solutions of NaCl are prepared in 1 liter of distilled water to give a final concentration in the culture of 33.33 g/l. Solutions are filter sterilized and added to the culture from a sterile bottle.
- Inductions usually take place on day 5 to 7 of a culture period. Stimulations usually occur within 24 hours and can continue for up to 7 days.
- Synthesis of alkaloids by suspension cultured Catharanthus roseus cells is enhanced by stressing the cultured c osmotically by addition to the culture of such inducers as ionic osmotic stressors such as halide salts e.g. NaCl, KCl FeCl 3 or organic osmotic stressors such as sugar alcohols and sugar acids.
- ionic osmotic stressors such as halide salts e.g. NaCl, KCl FeCl 3 or organic osmotic stressors such as sugar alcohols and sugar acids.
- Synthesis of alkaloids is also enhanced by a tion of anti-gibberellin compounds and other compounds such as abscissic acid which is a plant growth regulator. Yi of alkaloids are consequently increased.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Botany (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Abstract
On améliore la synthèse d'alkaloïdes par des cellules de Catharanthus roseus cultivées en suspension en sollicitant par voie osmotique les cellules cultivées, en y ajoutant des inducteurs tels que des agents aggressifs osmotiques ioniques du type sels haloïdes, par exemple NaCl, KCl et FeCl3, ou des agents aggressifs osmotiques organiques tels que des alcools de sucre ou des acides de sucre. On améliore également la synthèse des alcaloïdes en y ajoutant des composés anti-gibbérellines et d'autres composés tels que de l'acide abscissique qui est un régulateur de la croissance végétale. On augmente ainsi les rendements d'alcaloïdes.The synthesis of alkaloids is improved by Catharanthus roseus cells cultivated in suspension by osmotically invoking the cultured cells, by adding inducers such as ionic aggressive agents of the ionic type such as haloid salts, for example NaCl, KCl and FeCl3, or organic osmotic aggressive agents such as sugar alcohols or sugar acids. The synthesis of alkaloids is also improved by adding anti-gibberellin compounds and other compounds such as abscissic acid which is a regulator of plant growth. This increases the yields of alkaloids.
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US89293886A | 1986-08-04 | 1986-08-04 | |
US892938 | 1986-08-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
EP0277250A1 true EP0277250A1 (en) | 1988-08-10 |
Family
ID=25400744
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP87904973A Withdrawn EP0277250A1 (en) | 1986-08-04 | 1987-08-03 | Process for inducing secondary metabolite production in plant cultures and means thereof |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0277250A1 (en) |
JP (1) | JP2845443B2 (en) |
KR (1) | KR900004437B1 (en) |
CA (1) | CA1283874C (en) |
FI (1) | FI881491A (en) |
WO (1) | WO1988000968A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0378921A3 (en) * | 1988-12-21 | 1990-09-19 | Idaho Research Foundation, Inc. | Enhancement of plant metabolite production by timed elicitation |
EP1485064B1 (en) | 2002-03-20 | 2014-05-07 | Rachid Ennamany | Cosmetic composition comprising phytoalexines and method for production of phytoalexins |
WO2012074502A1 (en) * | 2010-11-29 | 2012-06-07 | Chayil Technologies, Llc | Secondary metabolite stimulation in photoautotrophic cultures |
WO2012130783A2 (en) * | 2011-03-27 | 2012-10-04 | Arch Chemicals Inc. | Modulating epigenetic dna methylation to cause cells to adopt dna methylation patterns associated with young cells |
WO2016120713A2 (en) | 2015-01-30 | 2016-08-04 | Naolys Sarl | Topical composition and method for preparing same |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2300131A1 (en) * | 1975-02-04 | 1976-09-03 | Synthelabo | Alkaloid prodn by culturing Vinca minor cells - in undifferentiated state in liq medium (BE030876) |
FR2470603A1 (en) * | 1979-12-07 | 1981-06-12 | Synthelabo | Anti-mitotic extracts of Catharanthus roseus G-Don - two new strains cr-1 and cr-2 produce extracts of high activity and low toxicity, whose activity is compared with that of vinblastine |
-
1987
- 1987-08-03 JP JP62504568A patent/JP2845443B2/en not_active Expired - Lifetime
- 1987-08-03 WO PCT/JP1987/000583 patent/WO1988000968A2/en not_active Application Discontinuation
- 1987-08-03 EP EP87904973A patent/EP0277250A1/en not_active Withdrawn
- 1987-08-03 KR KR1019880700360A patent/KR900004437B1/en not_active IP Right Cessation
- 1987-08-04 CA CA000543676A patent/CA1283874C/en not_active Expired - Lifetime
-
1988
- 1988-03-30 FI FI881491A patent/FI881491A/en not_active IP Right Cessation
Non-Patent Citations (1)
Title |
---|
See references of WO8800968A2 * |
Also Published As
Publication number | Publication date |
---|---|
FI881491A0 (en) | 1988-03-30 |
KR900004437B1 (en) | 1990-06-25 |
WO1988000968A2 (en) | 1988-02-11 |
KR880701774A (en) | 1988-11-05 |
FI881491A (en) | 1988-03-30 |
WO1988000968A3 (en) | 1988-03-24 |
JPH01500401A (en) | 1989-02-16 |
JP2845443B2 (en) | 1999-01-13 |
CA1283874C (en) | 1991-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Eilert et al. | Stimulation of sanguinarine accumulation in Papaver somniferum cell cultures by fungal elicitors | |
JP4769868B2 (en) | Method for producing corosolic acid by plant cell suspension culture | |
Berkov et al. | Plant sources of galanthamine: phytochemical and biotechnological aspects | |
Paniego et al. | Artemisia annua L.: dedifferentiated and differentiated cultures | |
Laurain et al. | Production of ginkgolide and bilobalide in transformed and gametophyte derived cell cultures of Ginkgo biloba | |
JPS6357591A (en) | Novel compound, manufacture and medicinal composition | |
CN105198885A (en) | Compound communesin I with anti-arrhythmias activity, and preparation method and application thereof | |
KR101920022B1 (en) | Method for mass production of viniferin through tissue culture from grape tree using stevioside | |
Kovalenko et al. | Secondary metabolites synthesis in transformed cells of Glycyrrhiza glabra L. and Potentilla alba L. as producents of radioprotective compounds | |
Sheludko et al. | Induction of alkaloid diversity in hybrid plant cell cultures | |
US10822628B2 (en) | Production of thapsigargins by thapsia cell suspension culture | |
Tallevi et al. | Stimulation of indole alkaloid content in vanadium-treated Catharanthus roseus suspension cultures | |
EP0277250A1 (en) | Process for inducing secondary metabolite production in plant cultures and means thereof | |
Roja et al. | Enhanced production of the polysaccharide arabinogalactan using immobilized cultures of Tinospora cordifolia by elicitation and in situ adsorption | |
CN100582233C (en) | Method for preparing krev alcohol and use for preparing anti-acetylcholinesterase medicine | |
Robeson et al. | The influence of plant extracts on phytotoxin production and growth rate of Alternaria helianthi | |
JP2967532B2 (en) | Method for producing taxane compound | |
CN107043795B (en) | Method for producing camptothecin and 10-hydroxycamptothecin by using camptotheca acuminata suspension cells | |
EP0226354A2 (en) | Method for the semi-continuous production of phytochemicals by plant cells cultured in vitro | |
CN115505023B (en) | An indole diterpene derivative derived from Aspergillus oryzae, preparation method and application thereof | |
KR100263950B1 (en) | Method of culturing mishima-saiko | |
EP0420470B1 (en) | Naphthopyran compounds | |
JP2813101B2 (en) | Production method of red pigment by statice cultured cells | |
Mukherjee et al. | Higher production of forskolin in genetically transformed cultures of Coleus forskohlii Briq induced by growth regulators | |
CN1101467C (en) | Ephedra cell ZHJ-25 CGMCC No.0359 and its induction method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19880405 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): BE DE FR GB IT |
|
17Q | First examination report despatched |
Effective date: 19910201 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 19910813 |